Best Medicines Coalition
The Best Medicines Coalition (BMC) is a national alliance of Canadian patient organizations and individual patient advocates who share a commitment to ensuring safe, timely and equitable access to evidence-based medicines for all Canadians. Representing millions of patients living with or affected by chronic disease or other illnesses, the organization is engaged in a range of related policy discussions, including pharmaceutical review, reimbursement, treatment, life cycle management and safety issues.
During 2016, GSK funded Best Medicines Coalition with:
- $20,000 in core funding
- $10,000 in project funding to increase the role of the patient voice in the discussion on National Pharmacare
GSK’s contributions represent 13.3% of the organization’s total revenue for 2016.